Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Human Vaccine Adjuvants market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Human Vaccine Adjuvantsmarket, defines the market attractiveness level of Human Vaccine Adjuvants market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Human Vaccine Adjuvants industry, describes the types of Human Vaccine Adjuvants market, the applications of major players and the market size, and deeply analyzes the current situation of the global Human Vaccine Adjuvants market and the development prospects and opportunities of Human Vaccine Adjuvants industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Human Vaccine Adjuvants market in Chapter 13.
By Player:
GSK
Avanti Polar Lipids
CSL Limited
Brenntag Biosector
Aphios Corporation
Seppic
SPI Pharma
Novavax
By Type:
Oral
Subcutaneous
Intramuscular
Other
By End-User:
Research Application
Commercial Application
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Human Vaccine Adjuvants Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Human Vaccine Adjuvants Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Human Vaccine Adjuvants Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Human Vaccine Adjuvants Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Human Vaccine Adjuvants Market Analysis and Outlook to 2022
-
7.1 Global Human Vaccine Adjuvants Consumption (2017-2022)
-
7.2 United States Human Vaccine Adjuvants Consumption (2017-2022)
-
7.3 Europe Human Vaccine Adjuvants Consumption (2017-2022)
-
7.4 China Human Vaccine Adjuvants Consumption (2017-2022)
-
7.5 Japan Human Vaccine Adjuvants Consumption (2017-2022)
-
7.6 India Human Vaccine Adjuvants Consumption (2017-2022)
-
7.7 South Korea Human Vaccine Adjuvants Consumption (2017-2022)
8 Region and Country-wise Human Vaccine Adjuvants Market Analysis and Outlook to 2028
-
8.1 Global Human Vaccine Adjuvants Consumption Forecast (2022-2028)
-
8.2 United States Human Vaccine Adjuvants Consumption Forecast (2022-2028)
-
8.3 Europe Human Vaccine Adjuvants Consumption Forecast (2022-2028)
-
8.4 China Human Vaccine Adjuvants Consumption Forecast (2022-2028)
-
8.5 Japan Human Vaccine Adjuvants Consumption Forecast (2022-2028)
-
8.6 India Human Vaccine Adjuvants Consumption Forecast (2022-2028)
-
8.7 South Korea Human Vaccine Adjuvants Consumption Forecast (2022-2028)
9 Global Human Vaccine Adjuvants Market Outlook by Types and Applications to 2022
-
9.1 Global Human Vaccine Adjuvants Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Oral Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Subcutaneous Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Intramuscular Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Human Vaccine Adjuvants Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Research Application Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Commercial Application Consumption and Growth Rate (2017-2022)
10 Global Human Vaccine Adjuvants Market Outlook by Types and Applications to 2028
-
10.1 Global Human Vaccine Adjuvants Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Subcutaneous Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Intramuscular Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Human Vaccine Adjuvants Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Research Application Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Commercial Application Consumption Forecast and Growth Rate (2022-2028)
11 Global Human Vaccine Adjuvants Import and Export Analysis (Top 5 Countries)
-
11.1 Global Human Vaccine Adjuvants Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Human Vaccine Adjuvants Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Human Vaccine Adjuvants Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Human Vaccine Adjuvants Market Competitive Analysis
-
14.1 GSK
-
14.1.1 GSK Company Details
-
14.1.2 GSK Human Vaccine Adjuvants Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 GSK Human Vaccine Adjuvants Product and Service
-
14.2 Avanti Polar Lipids
-
14.2.1 Avanti Polar Lipids Company Details
-
14.2.2 Avanti Polar Lipids Human Vaccine Adjuvants Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Avanti Polar Lipids Human Vaccine Adjuvants Product and Service
-
14.3 CSL Limited
-
14.3.1 CSL Limited Company Details
-
14.3.2 CSL Limited Human Vaccine Adjuvants Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 CSL Limited Human Vaccine Adjuvants Product and Service
-
14.4 Brenntag Biosector
-
14.4.1 Brenntag Biosector Company Details
-
14.4.2 Brenntag Biosector Human Vaccine Adjuvants Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Brenntag Biosector Human Vaccine Adjuvants Product and Service
-
14.5 Aphios Corporation
-
14.5.1 Aphios Corporation Company Details
-
14.5.2 Aphios Corporation Human Vaccine Adjuvants Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Aphios Corporation Human Vaccine Adjuvants Product and Service
-
14.6 Seppic
-
14.6.1 Seppic Company Details
-
14.6.2 Seppic Human Vaccine Adjuvants Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Seppic Human Vaccine Adjuvants Product and Service
-
14.7 SPI Pharma
-
14.7.1 SPI Pharma Company Details
-
14.7.2 SPI Pharma Human Vaccine Adjuvants Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 SPI Pharma Human Vaccine Adjuvants Product and Service
-
14.8 Novavax
-
14.8.1 Novavax Company Details
-
14.8.2 Novavax Human Vaccine Adjuvants Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Novavax Human Vaccine Adjuvants Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Human Vaccine Adjuvants
-
Figure Human Vaccine Adjuvants Picture
-
Table Global Human Vaccine Adjuvants Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Human Vaccine Adjuvants Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Human Vaccine Adjuvants Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Human Vaccine Adjuvants Consumption by Country (2017-2022)
-
Figure United States Human Vaccine Adjuvants Consumption and Growth Rate (2017-2022)
-
Table Europe Human Vaccine Adjuvants Consumption and Growth Rate (2017-2022)
-
Figure China Human Vaccine Adjuvants Consumption and Growth Rate (2017-2022)
-
Figure Japan Human Vaccine Adjuvants Consumption and Growth Rate (2017-2022)
-
Figure India Human Vaccine Adjuvants Consumption and Growth Rate (2017-2022)
-
Figure South Korea Human Vaccine Adjuvants Consumption and Growth Rate (2017-2022)
-
Figure Global Human Vaccine Adjuvants Consumption Forecast by Country (2022-2028)
-
Figure United States Human Vaccine Adjuvants Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Human Vaccine Adjuvants Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Human Vaccine Adjuvants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Human Vaccine Adjuvants Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Human Vaccine Adjuvants Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Human Vaccine Adjuvants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Consumption and Growth Rate (2017-2022)
-
Figure Global Subcutaneous Consumption and Growth Rate (2017-2022)
-
Figure Global Intramuscular Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Research Application Consumption and Growth Rate (2017-2022)
-
Figure Global Commercial Application Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Subcutaneous Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Intramuscular Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Application Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Commercial Application Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Human Vaccine Adjuvants Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Human Vaccine Adjuvants Export by Region (Top 5 Countries) (2017-2028)
-
Table GSK (Foundation Year, Company Profile and etc.)
-
Table GSK Human Vaccine Adjuvants Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK Human Vaccine Adjuvants Product and Service
-
Table Avanti Polar Lipids (Foundation Year, Company Profile and etc.)
-
Table Avanti Polar Lipids Human Vaccine Adjuvants Sales, Price, Value and Gross Profit (2017-2022)
-
Table Avanti Polar Lipids Human Vaccine Adjuvants Product and Service
-
Table CSL Limited (Foundation Year, Company Profile and etc.)
-
Table CSL Limited Human Vaccine Adjuvants Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSL Limited Human Vaccine Adjuvants Product and Service
-
Table Brenntag Biosector (Foundation Year, Company Profile and etc.)
-
Table Brenntag Biosector Human Vaccine Adjuvants Sales, Price, Value and Gross Profit (2017-2022)
-
Table Brenntag Biosector Human Vaccine Adjuvants Product and Service
-
Table Aphios Corporation (Foundation Year, Company Profile and etc.)
-
Table Aphios Corporation Human Vaccine Adjuvants Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aphios Corporation Human Vaccine Adjuvants Product and Service
-
Table Seppic (Foundation Year, Company Profile and etc.)
-
Table Seppic Human Vaccine Adjuvants Sales, Price, Value and Gross Profit (2017-2022)
-
Table Seppic Human Vaccine Adjuvants Product and Service
-
Table SPI Pharma (Foundation Year, Company Profile and etc.)
-
Table SPI Pharma Human Vaccine Adjuvants Sales, Price, Value and Gross Profit (2017-2022)
-
Table SPI Pharma Human Vaccine Adjuvants Product and Service
-
Table Novavax (Foundation Year, Company Profile and etc.)
-
Table Novavax Human Vaccine Adjuvants Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novavax Human Vaccine Adjuvants Product and Service
-
